Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib

Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib

Aicardi-Goutières syndrome (AGS) is a rare hereditary early-onset encephalopathy. The syndrome was first described in 1984, and is characterised by upregulation of the type I interferon (IFN) pathway, which is involved in the host immune response against viral infections, including SARS-CoV-2. Whils...

Full description

Bibliographic Details
Main Authors: Abirami Pararajasingam, Rachel E. Bradley, Jennifer Evans, Ashima Lowe, Richard Goodwin, Stephen Jolles
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pediatrics
Subjects:
Aicardi-Goutières syndrome
COVID-19
ruxolitinib
panniculitis
SAMHD1 mutation
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.837568/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.837568/full

Similar Items